Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: Experience of the French national surveillance, REA-RAISIN

Journal of Hospital Infection

Volumn 79, Issue 1, 2011, Pages 44-48

  Venier, A G ^a,h   Gruson, D ^b   Lavigne, T ^c   Jarno, P ^d   L'Heriteau F ^e   Coignard, B ^f   Savey, A ^g   Rogues, A M ^h  

^a Southwestern Regional Coordinating Centre for Nosocomial Infection Control (CCLIN)   (France)

^b HÔPITAL PELLEGRIN   (France)

^c Coordinating Centre for Nosocomial Infection Control Eastern Regions ^*  (France)

^d Coordinating Centre for Nosocomial Infection Control Western Regions ^*  (France)

^e Inter regional Co ordinating Centre for Nosocomial Infection Control   (France)

^f National Institute for Health Surveillance   (France)

^g Regional Coordinating Centre for Nosocomial Infection Control   (France)

^h INSERM U657   (France)

Author keywords

Hospital infection; Intensive care unit; Pneumonia; Pseudomonas aeruginosa; Resuscitation unit; Risk factors

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; FRANCE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INJURY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT TRANSPORT; PSEUDOMONAS PNEUMONIA; RISK FACTOR; TREATMENT DURATION; WARD;

ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; FEMALE; FRANCE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; RISK FACTORS;

EID: 80051469285     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.05.007     Document Type: Article

References (38)

1. Chastre J.C., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
2. National Nosocomial Infection Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999, 27:520-532.
3. Spencer R.C. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 1996, 15:281-285.
4. Fagon J.Y., Chastre J., Hance A.J., Montravers P., Novara A., Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993, 94:281-288.
5. Rello J., Rué M., Jubert P., et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997, 25:1862-1867.
6. Vallés J., Mariscal D., Cortés P., et al. Patterns of colonization by Pseudomonas aeruginosa in intubated patients: a 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia. Intens Care Med 2004, 30:1768-1775.
7. Rogues A.M., Boulestreau H., Lashéras A., et al. Contribution of tap water to patient colonisation with Pseudomonas aeruginosa in a medical intensive care unit. J Hosp Infect 2007, 67:72-78.
8. Lashéras A., Guisset O., Boulestreau H., et al. Reservoirs and transmission of Pseudomonas aeruginosa in intensive care unit. Med Mal Infect 2006, 36:99-104.
9. Corona-Nakamura A.L., Miranda-Novales M.G., Leaños-Miranda B., et al. Epidemiologic study of Pseudomonas aeruginosa in critical patients and reservoirs. Arch Med Res 2001, 32:238-242.
10. Desenclos J.C. RAISIN - a national programme for early warning, investigation and surveillance of healthcare-associated infection in France. Euro Surveill 2009, 14:19408. RAISIN Working Group.
11. Suetens C., Morales I., Savey A., et al. European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results. J Hosp Infect 2007, 65:171-173.
12. Langer M., Cigada M., Mandelli M., Mosconi P., Tognoni G. Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med 1987, 13:342-346.
13. Goldstein H., Pan H., Bynner J. A flexible procedure for analysing longitudinal event histories using a multilevel model. Understanding Statistics 2004, 3:85-89.
14. Larsen K., Merlo J. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol 2005, 161:81-88.
15. Merlo J., Chaix B., Ohlsson H., et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 2006, 60:290-297.
16. Thuong M., Arvaniti K., Ruimy R., et al. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J Hosp Infect 2003, 53:274-282.
17. Rello J., Ausina V., Ricart M., et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 1994, 20:193-198.
18. Olson B., Weinstein R.A., Nathan C., Chamberlin W., Kabins S.A. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis 1984, 150:808-816.
19. Trouillet J.L., Chastre J., Vuagnat A., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998, 157:531-539.
20. Rello J., Sa-Borges M., Correa H., Leal S.R., Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999, 160:608-613.
21. Rello J., Ausina V., Ricart M., Castella J., Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993, 104:1230-1235.
22. Ahl J., Tham J., Walder M., Melander E., Odenholt I. Bacterial aetiology in ventilator-associated pneumonia at a Swedish university hospital. Scand J Infect Dis 2010, 42:469-474.
23. Aloush V., Navon-Venezia S., Seigman-Igra Y., Cabili S., Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother 2006, 50:43-48.
24. Berthelot P., Grattard F., Mahul P., et al. Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intens Care Med 2001, 27:503-512.
25. Cunningham J.B., Kernohan W.G., Rush T. Bed occupancy, turnover intervals and MRSA rates in English hospitals. Br J Nurs 2006, 15:656-660.
26. Griffiths P., Renz A., Hughes J., Rafferty A.M. Impact of organisation and management factors on infection control in hospitals: a scoping review. J Hosp Infect 2009, 73:1-14.
27. Vanderpas J., Louis J., Reynders M., Mascart G., Vandenberg O. Mathematical model for the control of nosocomial norovirus. J Hosp Infect 2009, 71:214-222.
28. Reis Miranda D., Moreno R., Iapichino G. Nine equivalents of nursing manpower use score (NEMS). Intensive Care Med 1997, 23:760-765.
29. O'Brien-Pallas L., Leatt P., Deber R., Till J.A. A comparison of workload estimates using three methods of patients classification. Can J Nurs Adm 1989, 2:16-23.
30. Hugonnet S., Chevrolet J.C., Pittet D. The effect of workload on infection risk in critically ill patients. Crit Care Med 2007, 35:76-81.
31. Gastmeier P., Sohr D., Geffers C., Rüden H., Vonberg R.P., Welte T. Early- and late-onset pneumonia: is this still a useful classification?. Antimicrob Agents Chemother 2009, 53:2714-2718.
32. Verhamme K.M., De Coster W., De Roo L., et al. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia. Infect Control Hosp Epidemiol 2007, 28:389-397.
33. Iregui M., Ward S., Sherman G., Fraser V.J., Kollef M.H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262-268.
34. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996, 22:387-394.
35. Gbaguidi-Haore H., Cholley P., Rabaud C., Bertrand X., Talon D. Multilevel modelling of the prevalence of hospitalized patients infected with Pseudomonas aeruginosa. Epidemiol Infect 2010, 16:1-9.
36. Blakely T.A., Woodward A.J. Ecological effects in multi-level studies. J Epidemiol Community Health 2000, 54:367-374.
37. Bou R., Aguilar A., Perpiñán J., et al. Nosocomial outbreak of Pseudomonas aeruginosa infections related to a flexible bronchoscope. J Hosp Infect 2006, 64:129-135.
38. Mesaros N., Nordmann P., Plésiat P., et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect 2007, 13:560-578.